Log in
NYSE:STE

Steris Stock Forecast, Price & News

$176.19
+3.37 (+1.95 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$173.00
Now: $176.19
$177.75
50-Day Range
$153.12
MA: $162.34
$175.91
52-Week Range
$105.69
Now: $176.19
$177.75
Volume537,612 shs
Average Volume616,945 shs
Market Capitalization$14.99 billion
P/E Ratio36.63
Dividend Yield0.93%
Beta0.71
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Read More
Steris logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.69 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP85915210
Phone353-1232-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$8.70 per share
Book Value$40.17 per share

Profitability

Net Income$407.61 million

Miscellaneous

Employees13,000
Market Cap$14.99 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$176.19
+3.37 (+1.95 %)
(As of 09/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock price been impacted by Coronavirus?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STE stock has increased by 21.3% and is now trading at $176.19.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris
.

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris
.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) released its quarterly earnings results on Monday, August, 3rd. The medical equipment provider reported $1.31 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.98 by $0.33. The medical equipment provider had revenue of $668.90 million for the quarter, compared to analysts' expectations of $643.38 million. Steris had a net margin of 13.69% and a return on equity of 16.24%. The firm's quarterly revenue was down 4.0% on a year-over-year basis. During the same quarter last year, the company posted $1.23 earnings per share.
View Steris' earnings history
.

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, August 3rd. Investors of record on Thursday, August 27th will be paid a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date is Wednesday, August 26th. This is a positive change from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history
.

What price target have analysts set for STE?

4 brokers have issued 12 month target prices for Steris' shares. Their forecasts range from $170.00 to $175.00. On average, they expect Steris' stock price to reach $172.50 in the next twelve months. This suggests that the stock has a possible downside of 2.1%.
View analysts' price targets for Steris
.

Are investors shorting Steris?

Steris saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,140,000 shares, an increase of 24.0% from the August 15th total of 919,500 shares. Based on an average trading volume of 459,000 shares, the short-interest ratio is presently 2.5 days.
View Steris' Short Interest
.

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Gilead Sciences (GILD), Home Depot (HD), Pfizer (PFE), AT&T (T), Mastercard (MA) and Medtronic (MDT).

Who are Steris' key executives?

Steris' management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $176.19.

How big of a company is Steris?

Steris has a market capitalization of $14.99 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

What is Steris' official website?

The official website for Steris is www.steris.com.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.